A Randomized Phase III Study Of Sublobar Resection (Sr) Versus Stereotactic Ablative Radiotherapy (Sabr) In High Risk Patients With Stage I Non-Small Cell Lung Cancer (Nsclc)
Posted Date: Dec 12, 2017
- Investigator: Sandra Starnes
- Specialties: Hematology/Oncology, Oncology, Cancer
- Type of Study: Drug
The purpose of this study is to compare the results of two standard treatments. The two treatments include sublobar resection and radiation. Sublobar resection is the removal of a small portion of a lung. Radiation, orstereotactic ablative radiotherapy, is radiation given by a specialized x-ray machine that targets your lung cancer.
To Be Eligible To Participate In This Study, Participants Must Have Lung Cancer, Or A Lung Nodule Suspicious For Lung Cancer Which May Be Removable With Surgery. Typically This Is Done By Removing A Lobe Of The Lung. Due To Certain Risks, You Would Require A Surgery Removing A Smaller Portion Of The Lung.
Phase Iii, Stu-022015-069, Lung, Non-Small Cell Lung Cancer, Cancer
For More Information:
Uc Cancer Institute